Smith & Nephew Appoints New Non-Executive Director
Ticker: SNNUF · Form: 6-K · Filed: Mar 28, 2024 · CIK: 845982
| Field | Detail |
|---|---|
| Company | Smith & Nephew PLC (SNNUF) |
| Form Type | 6-K |
| Filed Date | Mar 28, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $5.2 billion |
| Sentiment | neutral |
Sentiment: neutral
Topics: directorate-change, governance
TL;DR
Smith & Nephew adds Vanda Vicsek as Non-Exec Director starting April 1st, bringing digital expertise.
AI Summary
Smith & Nephew plc announced on March 28, 2024, a change in its directorate. Ms. Vanda Vicsek has been appointed as a Non-Executive Director, effective April 1, 2024. Ms. Vicsek brings extensive experience in digital transformation and technology from her previous roles.
Why It Matters
The appointment of a director with digital transformation experience could signal a strategic focus on technology adoption and innovation within the company's operations.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of a directorate change and does not present immediate financial or operational risks.
Key Players & Entities
- Smith & Nephew plc (company) — Registrant
- Vanda Vicsek (person) — Appointed Non-Executive Director
FAQ
When does Vanda Vicsek's appointment as Non-Executive Director become effective?
Ms. Vanda Vicsek's appointment as a Non-Executive Director is effective April 1, 2024.
What is the primary area of expertise Vanda Vicsek brings to Smith & Nephew?
Ms. Vicsek brings extensive experience in digital transformation and technology.
What type of director is Vanda Vicsek being appointed as?
Ms. Vanda Vicsek is being appointed as a Non-Executive Director.
What is the filing date of this Form 6-K?
This Form 6-K was filed on March 28, 2024.
What is the company's principal executive office address?
The company's principal executive office is located at Building 5, Croxley Park, Hatters Lane, Watford, England, WD18 8YE.
Filing Stats: 1,003 words · 4 min read · ~3 pages · Grade level 20 · Accepted 2024-03-28 07:29:29
Key Financial Figures
- $5.2 billion — ountries, and generated annual sales of $5.2 billion in 2022. Smith+Nephew is a constituent
Filing Documents
- a5596i.htm (6-K) — 29KB
- 0001654954-24-003767.txt ( ) — 30KB
Forward-looking Statements
Forward-looking Statements   This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading profit margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements.
Forward-looking statements involve known and unknown risks,
Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: risks related to the impact of Covid, such as the depth and longevity of its impact, government actions and other restrictive measures taken in response, material delays and cancellations of elective procedures, reduced procedure capacity at medical facilities, restricted access for sales representatives to medical facilities, or our ability to execute business continuity plans as a result of Covid; economic and financial conditions in the markets we serve, especially those affecting healthcare providers, payers and customers (including, without limitation, as a result of Covid); price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal and financial compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers (including, without limitation, as a result of Covid); competition for qualified personnel; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; relationships with healthcare professionals; reliance on information technology and cybersecurity; disruptions due to natural disasters, weather and climate change related events; changes in customer and other stakeholder sustainability expectations; changes in taxation reg
forward-looking statements attributable to Smith+Nephew are
forward-looking statements attributable to Smith+Nephew are qualified by this caution. Smith+Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith+Nephew's expectations.   ◊   Trademark of Smith+Nephew. Certain marks registered in US Patent and Trademark Office.    
SIGNATURES
SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.             Smith & Nephew plc     (Registrant)             Date: March 28, 2024 By: /s/ Helen Barraclough     Helen Barraclough     Company Secretary